made about 10x my BIEL investment

since selling not too long ago.

The "cheers" picture in the office with the little plastic cups was all I needed to see.

180 days my butt.

Sold 95% of BIEL investment, now 300%+++

Still have a straggling 250k shares or something, but I had deep million before selling weeks ago. Thankfully I've put that previously dead money back to work and have already tripled it.

It's unfortunate because there may be money to be made with this product, but I just didn't feel like the company was making any progress. There's always news of a deal around the corner, or a over-hyped deal that never seems to translate into sales - followed by excuses. Rinse repeat for years and years. It gets old.

That's what I thought. Phony BIEL bids.

Didn't take many of my 1,666,666 lots selling at the .0007 bid to scramble you to remove those bids did it. Fake prop bids.

Keep your bids up please.

Time to dump some 666's.

What a beautiful time to preposition some hard earned money.

Cheers to the most talked about thing in pain.

https://twitter.com/keith_nalepka/status/1223352910022631425/photo/1

Keith must have meant PPS pain.

:Amy Winehouse Muzak intensifies: in the background.

I sense sarcasm.

Eh... that's not true.

As much as I appreciate a contrarian viewpoint, it's hard to say there's "ZERO VALUE" here. With $30+ million in losses, the company has clearly used some of that to establish assets like product line, packaging, meeting regulatory requirements, supply chain, etc. right?

Silly multi-decimal price quotes and too many billions of shares aside, the public values this company somewhere around 20-something million today, yes? I actually consider this number to be high because of everything bad that goes along with penny stocks, and I think a lot of people are "trapped" in this stock. Not selling because of significant losses incurred and not buying more because (pick a reason).

The "not buying" part seems evident from the lackluster trading week we've had after the latest 510k clearance announcement.

Is it because this pool of investors is basically tapped out? Or is it because they've grown wise and weary to these under-performing cycles with BIEL?

Still, I think there's value here and the market for this type of product (maybe not BIEL's) could boom at any time and compared to other pie-in-sky companies. At least BIEL has products - which have gone through additional clearance reviews, packaging, distribution, etc. The only thing they seem to be lacking is someone who can move them in significant enough numbers to greatly increase the market-determined value of the company.

HOLD and HOLD ACCOUNTABLE.

Yep. Completely understand. Depending your investment size, you may just want to change your strategy to HOLD and HOLD ACCOUNTABLE. That is to say, when nonsense & excuses pop up, call them or complain about it here or elsewhere. If you've tried ActiPatch, you're free to review it. You're also free to do your DD and post analysis of the company and its history.

I want to give them the benefit of the doubt here, but time is running out. If there's no deals, then they should do the right then and update that any deals that may have been tied to so and so clearance have fallen through. If there are deals, then release the kraken and let us, shareholders and investors, tell you how much these deals are worth on the future speculative growth side.

There's always an asterisk

I caught that too.

Seems a little disrespectful to shareholders, no?

How did old spice make a comeback?

Should be a pretty good case example for marketing wizards.

Went from being the dying brand known for being every grandpas only bottle of combo cologne/aftershave to... 70+ SKU's on the shelves of my local walmart. Neat.

Possible for BIEL to learn something from this?

True - and hope so because

it's a pretty risky statement for him to have published. He even directed the "congratulatory" sounding message to shareholders. :cringe:

Even though this is a gutter-cap OTC stock, we all should know SEC has already been up their butts. Since they have some of my money, I really wish they had more sense and were more careful with their words.

Right, got it. So no deals?

Someone needs to ask Keith directly, or Kelly for that matter (since she encourages people to call her) if this NANS conference and some (paid/compensated?) PR is what Keith meant by BIEL becoming "the most talked about thing in pain". Sad.

I believe you don't.

I believe a lot of people didn't.

Why would we? He's a senior executive.

SEC: Spotlight on Microcap Fraud

As we get closer to the end of the week, without (yet!) being "the most talked about thing in pain"... been brushing up on some reading:

https://www.sec.gov/spotlight/microcap-fraud.shtml

From the page:

Also see the right sidebar. SEC still seems very interested and active in pursuing Microcap fraud.

The market had it nearly priced in.

>Hell, just a full musculoskeletal pain clearance news story would make his statement true.

If that's the case and Keith, as close as he is to sales, value, etc. is
sincerely going to say to an inquiring SEC that he thought that this long overdue, no-surprise FDA clearance for expanded use of a product already on the shelves, on AMAZON, etc. was suddenly going to make BIELCORP ...."the most talked about thing in pain" without a major partner to facilitate that talk, then we have big problems.

SEC does what they do. You misstep in a way that harms investors (and there are hundreds of posts here heralding Keith's post and how well the stock would perform this week) then they'll step in.

So really, for the good of BIEL I do hope they have a deal to announce VERY soon that will live up to the statement made by the BIELCORP senior executive. It's possible they do, but seriously risky IMO to have made that statement all things (past sales/current product lines) considered.

forget the PPS

It's a publicly traded company. The market takes in all the information and determines the value of the company.

Currently the market says BIEL is worth ~$24 million.

2 days left. Hopefully BIEL announces soon.

A great dream just got way closer. FDA clearance for musculoskeletal pain. The next week will transform the 8 people in this picture to the most talked about thing in pain. Cheers to all the shareholders taking the ride with BIEL!!! #teambiel pic.twitter.com/ALoDWVI3XM

— Keith Nalepka (@keith_nalepka) January 31, 2020

Not much difference between the time Elon Musk got ahead of himself with his statements, than Keith Nalepka as a senior exec of company making a statement that "The next week will transform the 8 people in this picture to the most talked about thing in pain"

For reference, this is what happened to Elon with SEC:
https://www.sec.gov/news/press-release/2018-226

IMO, to become "the most talked about thing in pain", would require a deal with a major company that is publicly traded.

This isn't disclosed in the financials?

Seems like it's disclosed in the financials:

It's not exactly good. I don't like a lot of it. Reading it triggers 100 additional questions. What IBEX and "OTHER" are owed and entitled to are detailed further in the document.

But isn't it there?

41.391 BILLION (or so?)

Just pulling names and numbers from the latest publicly available financial report....

I mean on one hand it's good that "other" seems to be mostly people close to the family. I guess. The additional private notes to named "outsiders" are a lot of shares, but tiny by comparison to IBEX + OTHER. IBEX or OTHER converting in a way where they need to file another AS increase is basically dropping a nuke on the public PPS... as it has been the last couple times AS increase was filed with MD. So hopefully they all have some sense and can be happy with the interest they're getting for now. Again, being mostly people close to the business, I'd assume that's probably being managed with understandings.

Other than that, I think the named notes can probably be dealt with using shares BIELCORP already has on shelf?

#NDASSTILLINPLACE

One of the hashtags From KW's last tweet.

= Non-Disclosure Agreements still in place.

That's first document you're going to put in place when working out a potential deal of any substance.

NDA_s_ (plural, though maybe typo) suggests multiple NDA's. Though she could mean each party of a single NDA. Considering 7 step plan steps 1 and 2, I'd assume 2-3 NDA's with different companies being thought of at the moment that hashtag was added though.

Oh well. Last post for the day. See you tomorrow.

P.S Calm Down, #mommoved is pretty funny.

Yeah I mean..DJO is big, right?

When you have <50mln cap it would be more than awesome to be doing business with billion dollar partners. Especially if they would commit to serious orders that would flip your financials around. I surely wouldn't turn them down for not being big pharma :)

Ah..then definitely follow the D. Watson thread.

Watson headed Ciba-Giegy and then CEO Novartis (YUUUGE...$210+ billion market cap today) for about 3 years during the transition of Ciba-Giegy to NVS, or whatever you would call it.

It goes without saying that he would still have contacts up and down Big Pharma who would pick up the phone and give him 5 minutes, minimum.

I'd speculate that if BAYER was kicking tires, that NVS knows that BAYER was kicking tires and wondered if they should be kicking tires, too.

The most talked about thing in pain.

Srinsocal, I think for that statement (from KN?) to actually to live up to the hype, the partner would have to be Big-Pharma huge. I.e. BAYER, GSK, Novartis (I suppose NVS introductions could be possible, considering BIEL engaging w/Douglas Watson), etc.

DJO as a (rumored here) potential partner is pretty big, I guess. I do see an article from Nov 2018 stating they were acquired by Colfax Corporation for $3.15 Billion, who itself currently "only" has ~4.15B market cap.

I don't think CFX or DJO is realistically on the map of resulting in BIEL becoming "the most talked about thing in pain." for landing some kind of deal there.

Soooo let's hope someone actually hooked up some big pharma discussions. I swear if the right people at BAYER were presented with some ideas OR Novartis thought BAYER might be interested... we might have something great transpire.

Unfortunately, KW's 7 step plan doesn't suggest anything like that is in the works to me IMO. Unless maybe a potential deal is tied to minimum sales through 2022 to allow for a "proving period" of sorts... but why bother? So it all just leads me to believe the statement is probably just a little on the hype side tied to "ortho" and "footcare" deals. Which is still great.

BIEL'ers beware of this "MarketWatch" release:


https://www.marketwatch.com/press-release/global-pain-relief-therapy-market-analysis-2019-top-profiles-players-are-johnson-johnson-services-inc-eli-lilly-company-merck-co-inc-pfizer-inc-abbott-laboratories-f-hoffmann-la-roche-ltd-djo-llc-breg-inc-beiersdorf-ag-2019-01-14

NOTE MarketWatch disclaimer at bottom:

ALSO NOTE START OF THE RELEASE:



The article was pushed through COMTEX by a PR company called "Hearaldkeeper".

Dangerous PR from company w/compromised site?

IMO dangerous for you to consider their release as any type of meaningful DD. IMO, they are just trying to associate a couple key clients company names with BIG PHARMA. There's no sensible reason for some of the small names to be mixed in there, unless maybe they were paid to be there.

Note the "MarketWatch" article is stated to be from: (Heraldkeeper via COMTEX) Comtex is a news aggregation service.

And the MW disclaimer bottom:

Now if you want to continue, you could carefully try to figure out who Heraldkeepr is (Hearaldkeeper.com?), but WARNING, it seems that their website is compromised and dishing out spyware/malware.

From their google cached webpage description:



Sounds like the right spot.

One question we should be asking

is how many shares we expect to see BIELCORP sell next week?

To me, selling ANY shares into this news is bad form and suggests they may not be expecting enough revenue/profits for operations and survival from these first couple of deals on KW's 7 point plan.

The problem with BIELCORP selling shares is what they notoriously do when they get close to running out.

Let's hope these are additional elements of the business operations that will change under KW's leadership.

500% move is realistic.

IMO. This puts you back slightly below the previous hot run to the .005 wall.

Again, if BIELCORP and shareholders here are not total fools, they'll make new investors pay (hopefully beyond last .005 resistance)for shares before throwing up any kind of wall of hundreds of millions of shares on the ASK. The MM's will still make the market at lower price points, but there's only so much blind-selling risk those market makers will take here if the ASK side of the market is crickets. The only thing for them to do is move price up, quickly, until they entice people to offer some shares up.

The bulk of tomorrows price range is very likely up to me, you, and BIELCORP.

>The product does not sell

It's a tough nut to crack as a new name on the shelves in pain management.

Deals (if they happen) with names like Dr. S. and with companies like the Ortho company being floated would seem to be a much better path to sales. BIELCORP folks have tried direct sales for awhile now right? They're clearly very bad at it...versus the sales predictions and expectations laid out here anyway. BUT that's not the end of the world. It simply may not be the path for BIELCORP. Recognizing their weaknesses could be good for us.

The Ortho company seems to be deeply hooked in to healthcare already. I haven't seen their numbers (I will look for them today) but I can say you can go to any thrift store in the USA and probably see some of their products like leg braces and coolers on the shelves. I think these are typically being paid for with insurance, gov programs and all of that. Definitely see potential going that route. Probably not huge direct-to-consumer margins, but then again, an Ortho company selling to healthcare may not be selling an Actipatch as Actipatch to their customers for $30 either so who knows.

.36? ~$8.3 billion valuation?

In what period of time?

Assuming your .36 possible target is without reverse splits here...

Since you're floating an actual PPS target as possible, please clarify by what period of time you feel that BIEL could achieve this valuation from the open market?

Kalio already $1.5mln indigogo campaign?

"Just place it on your skin between the brain and the pain!"

Haha ahhh gotta love this industry. Between your brain and the pain.

Relevant marketing:

Hundreds, huh? Wow. That's a lot.

1 Kalio = $119.

I think we're safe.

"It's reusable tho..."

Yeah, I think we're ok.

"Comes in a box with a bow?"

That's a no from me dog.

400 million surgical kits?

Where are you getting this number from? Over what period? and to what regions?

And how are you making the leap to suggest that this number of kits = 1:1 orders for BIEL?

Are you speaking towards a specific company or partner here?

If yes, how many units has this kit owner ordered/been shipped to date from BIELCORP?

If the number is extremely low, what have the obstacles been?

I disagree. Multi-Billion $

I strongly disagree there... billion dollar or multi-billion dollar valuations based on the company today and it's performance and losses to date would be very lofty goals.

I think KW is fairly grounded with her 7 step plan. It would be nice if some actual contractual commitments are disclosed to us shareholders from steps 1 and 2. I.e. Company X has agreed to purchase an initial order of ###### units and a minimum of ####### per year under this agreement.

NOTE: EVERY PENNY is ~$250MLN valuation.

Just keep this in mind as you set your expectations for the week at possibly unrealistic levels. This will help keep you grounded.

.01 = ~250,000,000 Valuation
.02 = ~500,000,000 Valuation
.03 = ~750,000,000 Valuation
.04 = ~1 BILLION DOLLAR VALUATION

and so on.

This is generically based on round number of 25 billion shares to help give you an approximate idea when you're setting expectations / making predictions.

** NOTE: I think BIEL currently has ~23BLN AS? If so a closer number would be $230MLN per penny, but $250mln as a rough number makes it easier to quickly scale estimations up/down.

Heard rumors long ago there was a buyer

or offer, which many might have considered fair or substantial and AW turned it down. Some here may know if that's true and who that company was? I know the company name that went along with the rumor, but since it's rumor (AFAIK) I won't repeat it here. I want to say the offer was $100 million or something like that? Ring any bells? It was not Bayer.

Anyway if true, could be that some people back then (years ago) thought it should have been sold, got any investments they had out with handsome profits and be done with it?

Now, some may have the same sentiment...(KW did post something with the final step after shipping X # of units in 2022, to 'sell the company & retire', after all right?), BUT with a handful of final-value increasing deals nearly done, it would only make sense for KW to see them through to completion to increase value of a planned sale rather than to try to get offers which a bunch of things in limbo or in progress.

I know of someone who is highly successful at building up little local or regional companies for 12-24 months, and selling them off for nice profits to people who want to actually run the business until the wheels fall off. Nothing wrong with that.

I used to say BIEL (with Actipatch products as "eSpirin") + BAYER (Aspirin) would be a match made in heaven. Selling to BAYER that is.

FDA approved vs. FDA cleared

For anyone that needs to know...

https://www.cnet.com/news/fda-approved-vs-fda-cleared-whats-the-difference/

Yeah. That's what we're afraid of.

We'll know next week.

Try to keep expectations grounded.

BIEL was already FDA cleared.

The new clearance may open additional doors for them and allow SKU consolidation. It will still take a lot of consistent hard work to convert any of this into significant sales revenue required be able to turn profits.

If you check KW's twitter, you can see that even she has set some difficult, but possibly attainable targets for herself and company (i.e. SHIP 1.5 mln devices in 12 months.)

If your expectations are higher than hers, then you're probably setting yourself up to be let down.

Pinky promise - NO SELL ORDERS until .005 is selling

I'm sure a lot of people here are planning to sell a few shares.

I'd do myself a huge favor and keep the sell orders off the order book until this thing retraces PAST that previous .005 wall.

THAT GOES FOR YOU TOO, BIELCORP. If you put any kind of offering-wall up before .005 you're absolutely fools.

Coincidentally, Feb 3rd

2017...was the last FDA clearance?

Interesting that another FDA clearance for additional use will be celebrated on the 3 year anniversary of that.

I disagree. DewmBoom posted facts and stats.

Can you clarify specifically which part of DewmBooms original post is utter nonsense?